NORMAL SITUATION

Cabinet de Cardiologie JORDANT

Company — Normal situation.

Financial year 2023 · Closed on 31/03/2023

Net result136,2 k €+52,8 %over 1 year
Gross margin183,4 k €+0,7 %over 1 year
Equity1,2 M €+12,9 %over 1 year

Identity

Source · BCE/KBO

Cabinet de Cardiologie JORDANT is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0881.727.525
Legal form
Private company with limited liability
Contributed capital
18 600,00 €
Latest accounts
31/03/2023
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20232022202120202019
Income statement
Gross margin183,4 k €182 k €322,9 k €241,8 k €273,9 k €
EBITDA181,2 k €163,9 k €320,1 k €239,8 k €271,7 k €
Operating result167,7 k €141 k €287,6 k €206,2 k €235,6 k €
Net result136,2 k €89,2 k €200,7 k €128,8 k €157,6 k €
Balance sheet
Equity1,2 M €1,1 M €963,7 k €792,9 k €664,1 k €
Total assets1,2 M €1,2 M €1,2 M €1 M €857,7 k €
Cash622,5 k €204,8 k €75,9 k €21,1 k €237,3 k €
Debts23,5 k €142,3 k €195,2 k €218,4 k €188,9 k €

Board of directors

Source · NBB, accounts to 31/03/2023

0 active · 2 ended

Ended mandates

DirectorMandates in this companyPeriod
Marie ALGHISI
Director03/01/2022 → 30/09/2024
Joseph, Léon, André, Ghi JORDANT
Directoruntil 30/09/2021Manageruntil 30/09/2021

Full financial information

Source · NBB
202320222021202020192018
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/04/202201/04/202101/04/202001/04/201901/04/201801/04/2017
Closing of the financial year31/03/202331/03/202231/03/202131/03/202031/03/201931/03/2018
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date04/10/202328/10/202219/11/202113/11/202017/10/201910/10/2018
General meeting07/09/202330/09/202230/09/202130/09/202030/09/201930/09/2018
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/03/202307/09/202304/10/2023FrenchPDF
Micro model31/03/202230/09/202228/10/2022FrenchPDF
Micro model31/03/202130/09/202119/11/2021FrenchPDF
Micro model31/03/202030/09/202013/11/2020FrenchPDF
Micro model31/03/201930/09/201917/10/2019FrenchPDF
Micro model31/03/201830/09/201810/10/2018FrenchPDF
Micro model31/03/201730/09/201720/11/2017FrenchPDF
Abridged model31/03/201630/09/201614/11/2016FrenchPDF
Abridged model31/03/201530/09/201521/10/2015FrenchPDF
Abridged model31/03/201430/09/201402/10/2014FrenchPDF
Abridged model31/03/201330/09/201329/10/2013FrenchPDF
Abridged model31/03/201231/10/201213/11/2012FrenchPDF
Abridged model31/03/201130/09/201104/10/2011FrenchPDF
Abridged model31/03/201030/09/201018/10/2010FrenchPDF
Abridged model31/03/200930/09/200912/10/2009FrenchPDF
Abridged model31/03/200830/09/200801/10/2008FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2023

0 active · 2 ended

Ended mandates

DirectorMandates in this companyPeriod
Marie ALGHISI
Director03/01/2022 → 30/09/2024
Joseph, Léon, André, Ghi JORDANT
Directoruntil 30/09/2021Manageruntil 30/09/2021

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution19/10/2023
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Mandates27/07/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares03/05/2018
    CAPITAL, ACTIONS
    PDF
  • Capital / shares04/06/2014
    OBJET - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates30/06/2008
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Other19/06/2006
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Name
Registered office
Annual accounts
Filings16 filings
Mandates
Marie ALGHISI
Joseph, Léon, André, Ghi JORDANT
2008200920102011201220132014201520162017201820192020202120222023202420252026
Cabinet de Cardiologie Jordant
Route de Xhoffraix 22, 4970 Stavelot
Director
DirectorManager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Route de Xhoffraix 22, 4970 Stavelot
accounts 2022 → 2023
Accounts 2023 · 2023-00473228

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Cabinet de Cardiologie Jordant
accounts 2022 → 2023
Accounts 2023 · 2023-00473228

Events

  1. 2023
    Annual accounts 2023136,2 k €↑
  2. 2022
    Annual accounts 202289,2 k €↓
  3. 2021
    Annual accounts 2021200,7 k €↑
  4. 2020
    Annual accounts 2020128,8 k €↓
  5. 2019
    Annual accounts 2019157,6 k €↑
  6. 2018
    Annual accounts 201896,7 k €↓
  7. 2017
    Annual accounts 2017115 k €↑
  8. 2016
    Annual accounts 2016105,3 k €↓
  9. 2015
    Annual accounts 2015135,5 k €↑
  10. 2014
    Annual accounts 2014117,1 k €↓
  11. 2013
    Annual accounts 2013220,3 k €↑
  12. 2012
    Annual accounts 2012136,7 k €↑
  13. 2011
    Annual accounts 2011104,8 k €↑
  14. 2010
    Annual accounts 201078,5 k €↓
  15. 2009
    Annual accounts 2009103 k €↓
  16. 2008
    Annual accounts 2008166,2 k €